225 related articles for article (PubMed ID: 11489469)
21. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
Liu Q; Wang M; Hu Y; Xing H; Chen X; Zhang Y; Zhu P
Leuk Lymphoma; 2014 Apr; 55(4):892-8. PubMed ID: 23962073
[TBL] [Abstract][Full Text] [Related]
22. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.
Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA
Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480
[TBL] [Abstract][Full Text] [Related]
23. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
Sperling C; Büchner T; Creutzig U; Ritter J; Harbott J; Fonatsch C; Sauerland C; Mielcarek M; Maschmeyer G; Löffler H
Leuk Lymphoma; 1995 May; 17(5-6):417-26. PubMed ID: 7549832
[TBL] [Abstract][Full Text] [Related]
24. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.
Lauria F; Raspadori D; Rondelli D; Ventura MA; Fiacchini M; Visani G; Forconi F; Tura S
Leukemia; 1997 Dec; 11(12):2075-8. PubMed ID: 9447823
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
26. Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts.
Dalal BI; Wu V; Barnett MJ; Horsman DE; Spinelli JJ; Naiman SC; Shepherd JD; Nantel SH; Reece DE; Sutherland HJ; Klingemann HG; Phillips GL
Leuk Lymphoma; 1997 Jul; 26(3-4):299-306. PubMed ID: 9322892
[TBL] [Abstract][Full Text] [Related]
27. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
29. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
30. CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
Ciolli S; Leoni F; Caporale R; Pascarella A; Salti F; Rossi-Ferrini P
Haematologica; 1993; 78(3):151-5. PubMed ID: 7690733
[TBL] [Abstract][Full Text] [Related]
31. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
[TBL] [Abstract][Full Text] [Related]
33. [Expression of AC133 Antigen on Acute Leukemia Cells].
Yu H; Chang Y; Liu YR; Fu JY; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Mar; 9(1):26-29. PubMed ID: 12578640
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
[TBL] [Abstract][Full Text] [Related]
35. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
36. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.
Raspadori D; Lauria F; Ventura MA; Rondelli D; Visani G; de Vivo A; Tura S
Leuk Res; 1997 Jul; 21(7):603-7. PubMed ID: 9301680
[TBL] [Abstract][Full Text] [Related]
37. CD133 (AC133) expression on AML cells and progenitors.
Vercauteren SM; Sutherland HJ
Cytotherapy; 2001; 3(6):449-59. PubMed ID: 11953029
[TBL] [Abstract][Full Text] [Related]
38. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
Bradbury DA; Zhu YM; Russell NH
Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
[TBL] [Abstract][Full Text] [Related]
40. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
